Advanced Glycation End Products and Receptor for Advanced Glycation End Products in AA Amyloidosis
- 1 April 2003
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 162 (4), 1213-1220
- https://doi.org/10.1016/s0002-9440(10)63917-x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques.Neuroscience Letters, 2002
- Advanced glycation end products in children with chronic renal failure and type 1 diabetesPediatric Nephrology, 2002
- Proteolysis of AA Amyloid Fibril Proteins by Matrix Metalloproteinases-1, -2, and -3The American Journal of Pathology, 2001
- Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A proteinThe Lancet, 2001
- A Putative Role for Cathepsin K in Degradation of AA and AL AmyloidosisThe American Journal of Pathology, 2001
- Inflammation and advanced glycation end products in uremia: Simple coexistence, potentiation or causal relationship?Kidney International, 2001
- Inflammation and advanced glycation end products in uremia: Simple coexistence, potentiation or causal relationship?Kidney International, 2001
- Alzheimer's disease – synergistic effects of glucose deficit, oxidative stress and advanced glycation endproductsJournal of Neural Transmission, 1998
- The classification of amyloid deposits in clinicopathological practiceHistopathology, 1996
- Immunohistochemical study with anti‐advanced glycation end‐products antibody in murine amyloidosisPathology International, 1996